bioRxiv · 10.64898/2026.07.08.736836
Generation of hypoimmunogenic gastric insulin-secreting organoids
Abstract
Gastric insulin-secreting organoids (GINS) represent a promising source of {beta}-like cells for type 1 diabetes (T1D) therapy. In same-donor comparisons with induced pluripotent stem cell-derived islets (iPSC-islets), GINS displayed robust glucose responsiveness and reduced expression of key T1D autoantigens. Importantly, GINS exhibited decreased susceptibility to cytotoxicity mediated by engineered HLA-matched preproinsulin-specific effector T cells (Avatar Teffs) and a distinct transcriptional profile enriched for immune-modulatory and stress-adaptive gene programs. To enhance immune evasion, we engineered gastric stem cells to overexpress Programmed Death Ligand 1 (PD-L1) in an inducible manner. PD-L1+ GINS maintained normal functionality, while exhibiting improved survival under allogeneic Avatar Teff challenge in a MHC class I-independent fashion. We evaluated PD-L1-mediated protection against autologous Avatar Teff attack using an endothelialized microfluidic platform recapitulating physiologic immune interactions. T cells show reduced infiltration into PD-L1 GINS, resulting in significantly higher organoid viability compared to control GINS. Together, these findings identify GINS as a functional and engineerable {beta}-like cell platform with intrinsic hypoimmunogenic features, and support PD-L1 engineering as a strategy to enhance immune protection for both allogeneic and autologous transplantation in T1D.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Dattoli, A. A., Brown, M. E., Feinsten, Z., Pearson, B., Lang, Y., Polavarapu, V., Zhou, M., Nachman, R., Kelemen, Y., Rafii, S., Creusot, R. J., Brusko, T., Zhou, J., Huang, X.. 2026-07-13. Generation of hypoimmunogenic gastric insulin-secreting organoids. https://doi.org/10.64898/2026.07.08.736836
Cite the original work for its findings. Save a collection to share your selection of sources.